Picture of Amneal Pharmaceuticals logo

AMRX — Amneal Pharmaceuticals Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Momentum

Relative Strength (%)
1m+3.24%
3m-23.24%
6m-11.48%
1yr-24.09%
Volume Change (%)
10d/3m-25.52%
Price vs... (%)
52w High-39.56%
50d MA-2.74%
200d MA-13.26%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.89%
Return on Equity4.29%
Operating Margin7.82%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue$m824.43775.791,662.991,626.371,992.522,096.172,169.7418.29%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/a+700.51+2.74n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Amneal Pharmaceuticals EPS forecast chart

Profile Summary

Amneal Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the developing, manufacturing, marketing and distributing high-value generic and branded specialty pharmaceutical products across a broad array of dosage forms and therapeutic areas. It operates in three segments, which include Generics, Specialty and AvKARE. The Generics segment provides prescription pharmaceutical products. The Specialty Pharma is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system (CNS) disorders. AvKARE segment provides pharmaceuticals, medical and surgical products and services to governmental agencies. Its other pipeline includes 505(b)(2) drugs and complex generics.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
October 4th, 2017
Public Since
March 16th, 2009
No. of Employees
5,500
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
301,488,245

AMRX Share Price Performance

Latest News for AMRX

Upcoming Events for AMRX

Q4 2021 Amneal Pharmaceuticals Inc Earnings Release

Q1 2022 Amneal Pharmaceuticals Inc Earnings Release

Amneal Pharmaceuticals Inc Annual Shareholders Meeting

Similar to AMRX

Picture of Abbvie logo

Abbvie

us flag iconNew York Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Catalent logo

Catalent

us flag iconNew York Stock Exchange

Picture of Dr Reddy's Laboratories logo

Dr Reddy's Laboratories

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email